Clinically evident venous thromboembolic events in children with brain tumors - 24/08/11
Doi : 10.1016/j.jpeds.2004.05.055
Steven R. Deitcher, MD ⁎ 
, Amar Gajjar, MD, Larry Kun, MD, Richard L. Heideman, MD
, Amar Gajjar, MD, Larry Kun, MD, Richard L. Heideman, MD From the Section of Hematology and Coagulation Medicine, Department of Hematology-Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio; the Divisions of Neuro-oncology and Radiation Oncology, St Jude Children's Research Hospital, Memphis, Tennessee; and the Division of Pediatric Hematology/Oncology, Children's Hospital of New Mexico, Albuquerque, New Mexico
Reprint requests: Steven R. Deitcher, MD, 675 Almanor Ave, Sunnyvale, CA 94085.Abstract |
We evaluated the incidence and significance of central venous access device dysfunction and symptomatic major thrombosis in 253 pediatric patients with brain tumors. Central venous access device dysfunction was a common complication (28.4%) and was associated with major thrombosis development and a reduced overall survival rate. Major thrombosis was relatively uncommon (2.8%).
Le texte complet de cet article est disponible en PDF.Mots-clés : CVAD, VTE
Plan
| Supported in part by the American Lebanese Syrian Associated Charity (ALSAC). |
© 2004
Elsevier Inc. Tous droits réservés.
Vol 145 - N° 6
P. 848-850 - décembre 2004 Retour au numéro
Article précédent
- Stroke after varicella vaccination
- Elaine Wirrell, Michael D. Hill, Taj Jadavji, Adam Kirton, Karen Barlow
- Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome
- Elisabetta Cortis, Fabrizio De Benedetti, Antonella Insalaco, Stefania Cioschi, Flaminia Muratori, Leila E. D'Urbano, Alberto G. Ugazio
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?